Xenon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	545.87	199.16	142.71	148.64	57.24	175.69
Short-Term Investments	548.88	349.72	484.19	489.44	534.85	376.09
Cash & Short-Term Investments	1,095	548.89	626.91	638.08	592.09	551.77
Cash Growth	99.18%	-12.45%	-1.75%	7.77%	7.31%	211.74%
Accounts Receivable	-	-	-	0.87	0.99	2.77
Other Receivables	1.17	1.37	1.47	-	-	-
Total Trade Receivables	1.17	1.37	1.47	0.87	0.99	2.77
Other Current Assets	10.72	10.39	6.89	6.01	7.23	4.48
Total Current Assets	1,107	560.65	635.26	644.96	600.3	559.02
Net Property, Plant & Equipment	14.58	15.35	18.22	18.85	16.91	12.52
Long-Term Investments	244.87	37.15	127.5	292.79	128.68	-
Other Long-Term Assets	20.72	20.02	17.16	8.2	8.26	0.47
Total Assets	1,387	633.16	798.14	964.8	754.15	572.01
Accounts Payable	38.25	40.26	34.22	25.97	22.21	13.72
Current Portion of Leases	1.56	1.53	1.37	1.3	0.49	0.61
Total Current Liabilities	39.82	41.79	35.59	27.27	22.7	14.32
Long-Term Leases	5.93	6.41	7.65	9.6	9.95	7.65
Other Long-Term Liabilities	3.25	3.2	-	-	-	-
Total Long-Term Liabilities	9.18	9.61	7.65	9.6	9.95	7.65
Total Liabilities	48.99	51.4	43.24	36.88	32.65	21.97
Preferred Stock	-	-	-	-	-	7.73
Common Stock	2,422	1,599	1,457	1,436	1,065	783.17
Additional Paid-in Capital	264.88	228.23	199.15	156.76	142.11	117.5
Accumulated Other Comprehensive Income	-1.21	0.34	-1.61	-0.08	-3	-0.99
Retained Earnings	-1,348	-1,245	-899.47	-665.14	-482.75	-357.37
Shareholders' Equity	1,338	581.76	754.9	927.92	721.5	550.03
Total Liabilities & Equity	1,387	633.16	798.14	964.8	754.15	572.01
Total Debt	7.49	7.94	9.02	10.9	10.44	8.26
Net Cash (Debt)	1,087	540.94	617.89	627.18	581.65	543.52
Net Cash Growth	100.99%	-12.45%	-1.48%	7.83%	7.02%	212.94%
Net Cash Per Share	13.35	6.83	7.93	9.38	9.61	12.46
Book Value	1,338	581.76	754.9	927.92	721.5	550.03
Book Value Per Share	16.43	7.34	9.69	13.87	11.92	12.61
Tangible Book Value	1,338	581.76	754.9	927.92	721.5	550.03
Tangible Book Value Per Share	16.43	7.34	9.69	13.87	11.92	12.61

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q